ICU Medical, Inc. (ICUI:NASDAQ) closed at $166.62 on October 23, 2026, down 1.02% on the day. The stock trades 13.6% below its 52-week high of $192.85 and 47.0% above its 52-week low of $113.37. Over the past year, it gained 34.9%. ICU Medical, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 23, 2025, ICUI closed higher on 113 days (45%). Its best day was August 7, 2026 (+10.93%) and its worst was April 29, 2026 (-4.59%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 2 times.
ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein for use in hospitals and ambulatory clinics. The company's infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors. It also provides critical care products that are used to monitor signs, as well as physiological functions of organ systems. The company's critical care products comprises hemodynamic monitoring systems and SafeSet closed blood sampling and conservation systems, as well as sensing catheters, Lopez Valve, and cables and accessories for hemodynamic monitoring. In addition, it offers a line of oncology products, which are used to prepare and deliver hazardous medications for use in chemotherapy, such as ChemoLock and ChemoClave closed system transfer devices and components, and Diana hazardous drug compounding systems. Th...
Find more stocks like ICUI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.